Home › Funds › Liberty Mutual Group Asset Management Inc. › RYTM
Liberty Mutual Group Asset Management Inc. position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Liberty Mutual Group Asset Management Inc. reported holding 880 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$98K, representing 0.01% of its reported portfolio and ranking #36 among its reported holdings. Liberty Mutual Group Asset Management Inc. has disclosed RYTM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Liberty Mutual Group Asset Management Inc.'s RYTM position evolved
Liberty Mutual Group Asset Management Inc. first disclosed a stake in RYTM in Q1 2026 at 20,514 shares (US$1.8M). Across 2 filings, Liberty Mutual Group Asset Management Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 880 shares valued at US$98K — a reduction of -19,634 shares quarter over quarter.. Notable position changes include a 96% trim in Q2 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 20.51K | $1.78M | New |
| Q2 2026 | 880 | $97.71K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RYTM and 13F data
RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RYTM
- RA CAPITAL MANAGEMENT, L.P. 6.67M sh · $740.22M · Q2 2026
- BAKER BROS. ADVISORS LP 5.60M sh · $622.27M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.59M sh · $287.16M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.21M sh · $245.22M · Q2 2026
- Polar Capital Holdings Plc 1.66M sh · $184.71M · Q2 2026
- Checkpoint Capital L.P. 1.19M sh · $131.68M · Q2 2026
- Siren, L.L.C. 1.14M sh · $126.16M · Q2 2026
- Rock Springs Capital Management LP 692.60K sh · $76.90M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $61.07M · Q2 2026
- Sofinnova Investments, Inc. 408.03K sh · $45.30M · Q2 2026
- BRAIDWELL LP 381.13K sh · $42.32M · Q2 2026
More on Liberty Mutual Group Asset Management Inc.
FAQ
How long has Liberty Mutual Group Asset Management Inc. held RYTM?
Liberty Mutual Group Asset Management Inc. has disclosed RYTM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Liberty Mutual Group Asset Management Inc.'s current position in RYTM?
As of Q2 2026, Liberty Mutual Group Asset Management Inc. holds 880 shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $97.71K, representing 0.01% of its reported portfolio and ranking #36.
Has Liberty Mutual Group Asset Management Inc. been buying or selling RYTM?
In the latest 13F filing (Q2 2026), Liberty Mutual Group Asset Management Inc. reduced its position in RYTM.
Which other funds hold RYTM?
Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.